相似文献
1
Multifocal Head and Neck Paraganglioma Evaluated with Different PET Tracers: Comparison Between Fluorine-18-Fluorodeoxyglucose and Gallium-68-Somatostatin Receptor PET/CT.
Nucl Med Mol Imaging. 2013 Sep;47(3):218-9. doi: 10.1007/s13139-013-0204-x. Epub 2013 May 7.
2
Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
Clin Nucl Med. 2013 Dec;38(12):e458-62. doi: 10.1097/RLU.0b013e31827088d9.
3
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review.
Q J Nucl Med Mol Imaging. 2013 Jun;57(2):122-33.
4
Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
J Clin Endocrinol Metab. 2011 Sep;96(9):2779-85. doi: 10.1210/jc.2011-0333. Epub 2011 Jul 13.
5
Comparison of gallium-68 somatostatin receptor and F-fluorodeoxyglucose positron emission tomography in the diagnosis of neuroendocrine tumours: A systematic review and meta-analysis.
Hell J Nucl Med. 2020 May-Aug;23(2):188-200. doi: 10.1967/s002449912108. Epub 2020 Jul 27.
6
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
J Nucl Med. 2013 Jun;54(6):841-7. doi: 10.2967/jnumed.112.115485. Epub 2013 Mar 21.
7
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):569-80. doi: 10.1007/s00259-011-2031-6. Epub 2012 Jan 6.
8
Head-to-head comparison between F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas.
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):979-987. doi: 10.1007/s00259-016-3605-0. Epub 2017 Jan 3.
9
Pre-operative ⁶⁸Ga-DOTANOC somatostatin receptor PET/CT imaging demonstrating multiple synchronous lesions in a patient with head and neck paraganglioma.
Rev Esp Med Nucl Imagen Mol. 2014 Nov-Dec;33(6):374-7. doi: 10.1016/j.remn.2013.11.002. Epub 2014 Jul 17.
10
Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
Nucl Med Commun. 2016 Sep;37(9):891-8. doi: 10.1097/MNM.0000000000000530.
引用本文的文献
1
(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer.
Pharmaceuticals (Basel). 2020 Mar 5;13(3):39. doi: 10.3390/ph13030039.
2
Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.
Oncotarget. 2017 Sep 23;8(52):89958-89969. doi: 10.18632/oncotarget.21194. eCollection 2017 Oct 27.
本文引用的文献
1
Role of (18)F-FDG PET/CT, (123)I-MIBG SPECT, and CT in Restaging Patients Affected by Malignant Pheochromocytoma.
Nucl Med Mol Imaging. 2011 Jun;45(2):125-31. doi: 10.1007/s13139-011-0083-y. Epub 2011 May 3.
2
Simultaneous adrenal pheochromocytoma and carotid body paraganglioma in a woman.
Nucl Med Mol Imaging. 2013 Mar;47(1):67-8. doi: 10.1007/s13139-012-0179-z. Epub 2012 Oct 16.
3
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
J Nucl Med. 2013 Jun;54(6):841-7. doi: 10.2967/jnumed.112.115485. Epub 2013 Mar 21.
4
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
J Natl Cancer Inst. 2012 May 2;104(9):700-8. doi: 10.1093/jnci/djs188. Epub 2012 Apr 18.
5
Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.
Horm Metab Res. 2012 May;44(5):367-72. doi: 10.1055/s-0031-1299712. Epub 2012 Mar 7.
6
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
Endocrine. 2012 Aug;42(1):80-7. doi: 10.1007/s12020-012-9631-1. Epub 2012 Feb 20.
Zotero 插件